Avantor signs development agreement with Rubicon Research for pharma excipients

Avantor Performance Materials (Center Valley, PA) has signed a collaboration agreement with Rubicon Research (Mumbai) to develop, manufacture, and market products for the functional excipient market in pharmaceuticals. The companies plan to develop a novel gastroretentive excipient that can enable molecule delivery with a window of absorption, allowing targeted delivery and a therapeutic advantage with more options for the pharmaceutical excipient segment. “The Rubicon team is excited to work with Avantor in introducing this novel polymeric material as a...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers